Report: Sales for Antibiotics on Farms Rose

Amid concerns that the use of antibiotics may contribute to drug resistance, sales for use in livestock rose in recent years.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

According to a US Food and Drug Administration (FDA) report released last week (October 2), antibiotics sold for use on lWIKIMEDIA, RYAN THOMPSON/US DEPARTMENT OF AGRICULTUREivestock rose 16 percent from 2009 to 2012, despite concerns that overuse of antibiotics on farms contributes to drug resistance.

The New York Times (NYT) pointed out that cephalosporin sales rose, even though the FDA has targeted these medically important antibiotics in particular with special restrictions. According to the NYT, cephalosporin sales rose 8 percent in 2012, “confirming advocates’ fears that the agency’s efforts may not be having the desired effect.”

Earlier this year, the agency initiated a voluntary program for pharmaceutical companies to change the labeling on antibiotics in an effort to curb farmers’ using the drugs to beef up livestock. Environmental and consumer advocacy groups have said the initiative does not go far enough to restrict use to medically necessary situations.

Last week (September 29), California Governor Jerry Brown vetoed a bill that would establish rules similar to the guidelines set by the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies